- Home
- ENFY vs APRE Comparison
ENFY vs APRE Comparison
Compare ENFY & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENFY
- APRE
- Stock Information
- Founded
- ENFY 1987
- APRE 2006
- Country
- ENFY China
- APRE United States
- Employees
- ENFY N/A
- APRE N/A
- Industry
- ENFY
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENFY
- APRE Health Care
- Exchange
- ENFY NYSE
- APRE Nasdaq
- Market Cap
- ENFY 11.8M
- APRE 13.5M
- IPO Year
- ENFY N/A
- APRE 2019
- Fundamental
- Price
- ENFY $1.07
- APRE $1.87
- Analyst Decision
- ENFY
- APRE Strong Buy
- Analyst Count
- ENFY 0
- APRE 2
- Target Price
- ENFY N/A
- APRE $15.50
- AVG Volume (30 Days)
- ENFY 6.9K
- APRE 21.0K
- Earning Date
- ENFY 05-15-2025
- APRE 05-13-2025
- Dividend Yield
- ENFY N/A
- APRE N/A
- EPS Growth
- ENFY N/A
- APRE N/A
- EPS
- ENFY N/A
- APRE N/A
- Revenue
- ENFY $87,360,888.00
- APRE $1,502,581.00
- Revenue This Year
- ENFY N/A
- APRE N/A
- Revenue Next Year
- ENFY N/A
- APRE N/A
- P/E Ratio
- ENFY N/A
- APRE N/A
- Revenue Growth
- ENFY N/A
- APRE 157.63
- 52 Week Low
- ENFY $0.71
- APRE $1.85
- 52 Week High
- ENFY $3.15
- APRE $6.70
- Technical
- Relative Strength Index (RSI)
- ENFY N/A
- APRE 26.70
- Support Level
- ENFY N/A
- APRE $2.17
- Resistance Level
- ENFY N/A
- APRE $2.30
- Average True Range (ATR)
- ENFY 0.00
- APRE 0.17
- MACD
- ENFY 0.00
- APRE -0.01
- Stochastic Oscillator
- ENFY 0.00
- APRE 2.50
About ENFY ENLIGHTIFY INC
Enlightify Inc Formerly China Green Agriculture Inc is engaged in the business of fertilizer and agricultural products. It involves the research, development, production, distribution, and sale of humic acid-based compound fertilizers, blended fertilizers, organic compound fertilizers, slow-release fertilizers, concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizers and the development, production, and distribution of agricultural products, such as top-grade fruits, vegetables, flowers and colored seedlings in China. The company operates in four segments: Jinong (fertilizer production), Gufeng (fertilizer production), Yuxing (agricultural products production), and Antaeus (Bitcoin). All of its operations are conducted in China.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.